logo

Welcome Guest [Login | Register] StockFocus  •  Feedback
Google
 Check Quote

 Invest China

 Listed In US

 Misc



===================
A New Better Site for
CHINA

For Other ADRs :
BRAZIL
RUSSIA
INDIA

For Industry Group:
SOLAR ENERGY
HOME BUILDERS
CASINO

For Investing Gurus:
Warren Buffett John Paulson George Soros David Einhorn
For Real-Time Insider Trading:
Latest Buys/Sells
Buy Near 52Week Low
Buy Near 52Week High

And Much More At RealtionalStocks.com
===================


SciClone Pharmaceuticals, Inc. (NMS: SCLN)

Quote:SCLN Quotes on: Yahoo | Google
9.35
0.05 (0.54%)
May 26 - 4:00pm

5 day's Perf:6.03%
1 Month Perf:6.24%
3 Month Perf:6.68%
YTD Perf:1.63%
1 Year Perf:0.53%
Bid x Ask:9.00 x 10.30BidSize x AskSize:300 x 1600
Open:9.35Prev Close:9.30
Day's Range:9.18 - 9.4552wk Range:8.55 - 15.02
Volume:112716Average Vol:235880
Market Cap:483.69MEarnings:0.71
Dividend:N/ADividend Yield:N/A%
P/E ratio:13.15PEG ratio:0.72
Price/Book:2.06Price/Sale:2.89
1 yr price target:14.00Short Ratio:6.82


Quick Links for SCLN:
Financial Key Date on:YahooOption Prices on :MarketWatch
Technical Opinion:Barchar.comTechnical Charts:StockCharts.com
Earning Estimates:ReutersRatings:TheStreet.com
SEC Filings:EDGAR OnlineMessage Boards:Yahoo | TheLion

Latest Company News
SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCLN-US : October 11, 201611-Oct-16 08:16
SciClone Pharmaceuticals, Inc. ? Value Analysis (NASDAQ:SCLN) : September 29, 201629-Sep-16 10:16
SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCLN-US : September 28, 201628-Sep-16 08:16
SciClone Announces Progress In Advancing Clinical Pipeline For China Pharmaceuticals Market26-Sep-16 06:00
Soligenix (SNGX) and SciClone (SCLN) Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis12-Sep-16 11:15
Soligenix and SciClone Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis12-Sep-16 09:58
Soligenix and SciClone Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis12-Sep-16 07:00
SciClone To Present At Two Investor Conferences In September 20161-Sep-16 16:05
ETF?s with exposure to SciClone Pharmaceuticals, Inc. : August 31, 201631-Aug-16 11:49
Sciclone Pharmaceuticals Inc (SCLN) President & CEO Friedhelm Blobel Sold $5 million of Stocks18-Aug-16 23:15
SciClone posts 2Q profit9-Aug-16 17:59
SciClone posts 2Q profit9-Aug-16 17:59
SciClone Pharmaceuticals To Report Second Quarter 2016 Financial Results On August 9, 20169-Aug-16 16:30
SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements9-Aug-16 16:08
SciClone Reports Second Quarter 2016 Financial Results9-Aug-16 16:05
Q2 2016 Kandi Technologies Group Inc Earnings Release - Before Market Open9-Aug-16 07:07
Q2 2016 SciClone Pharmaceuticals Inc Earnings Release - Time Not Supplied9-Aug-16 07:07
Q2 2016 Bitauto Holdings Ltd Earnings Release - Before Market Open9-Aug-16 07:07
Q1 2017 Synutra International Inc Earnings Release - After Market Close9-Aug-16 07:07
SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Financial Statements and Exhibits3-Aug-16 14:02
 Global Indexes
US
Dow Jones:
N/AN/A
NASDAQ:
6210.194.94
S&P 500:
2415.820.75
CHINA
Shanghai:
Shanghai B:
HONG KONG
Hang Seng:
25701.6362.36
H-Shares:
10619.3439.67


*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the ChinaBizFocus.com web site, a user agrees that ChinaBizFocus.com shall be not liable for any errors or delays in the content.*